HOME >> BIOLOGY >> NEWS
AACR Annual Meeting showcases significant developments in understanding and targeting cancers

LOS ANGELES -- Data demonstrating genetic differences in individuals susceptibility to certain cancers as well as differences in how people respond to specific cancer treatments will take center stage when more than 17,000 scientists from around the world gather at the Los Angeles Convention Center April 14-18 for the 2007 Annual Meeting of the American Association for Cancer Research (AACR). Key data presented at the meeting will also include findings related to the safety and effectiveness of several new, high-profile cancer therapies and vaccines.

"Because of significant diagnostic and therapeutic advances such as personalized and targeted therapies that prolong patients lives, the number of people successfully managing and living with cancer continues to grow," said Geoffrey M. Wahl, Ph.D., President, AACR. "By hosting the largest meeting in the world of its kind where the science behind these significant developments is shared and analyzed by researchers at the leading edge of cancer study the AACR promotes clinical exchange with the goal of ensuring research discoveries translate directly into improved patient outcomes."

The theme of this years annual meeting, "A Century of Leadership in Science A Future of Cancer Prevention and Cures," commemorates the AACRs Centennial and underscores the remarkable scientific advances that researchers have achieved in the 100 years since the organizations founding, well as the critical importance of ongoing research.

The opening Centennial Ceremony will set an exciting and inspirational tone for a week of science and discovery, with a procession of young researchers bearing flags of all 70 AACR member nations, appearances by the University of Southern California (USC) Marching Band, the All-American Boys Choir and presentation of Centennial Medals and other honors to leading cancer researchers and advocates.

The opening plenary, "Translating a Century of Science into a Futu
'"/>

Contact: Staci Vernick Goldberg
goldberg@aacr.org
267-646-0616
American Association for Cancer Research
10-Apr-2007


Page: 1 2 3

Related biology news :

1. NY Stem Cell Foundations 2nd Annual Translational Stem Cell Research Conference
2. Illinois researchers presenting at ASPB Annual Meeting in Chicago, July 7-11
3. Highlighted sessions of ASBMBs 2007 Annual Meeting
4. Award lectures for ASBMBs 2007 Annual Meeting
5. AACR to present distinguished public service awards at 2007 Annual Meeting
6. New investigators tie for award at the 2007 AIUM Annual Convention
7. Presidential Recognition Awards presented at the 2007 AIUM Annual Convention
8. Advances in personalized medicine on agenda for 54th Society of Nucelar Medicine Annual Meeting
9. AACRs Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller
10. International Society for Heart and Lung Transplantation 27th Annual Meeting and Scientific Sessions
11. Research and program highlights of the 2007 Annual Clinical Genetics Meeting, March 21-25, 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/27/2020)... ... January 27, 2020 , ... Cytonus Therapeutics Inc. today announced ... entrepreneur, and former senior management consultant at McKinsey & Company who holds three ... investment firm. , “Chris Thorne has exceptional business acumen with a proven ...
(Date:1/23/2020)... ... January 23, 2020 , ... GIOSTAR/HEAMGEN ... from stem cells. The red blood cells are made utilizing a bioreactor ... for transfusion therapy and replaces the need for a human blood donor. ...
(Date:1/22/2020)... (PRWEB) , ... January 21, 2020 , ... Lifecycle Biotechnologies announces the new ... to each users’ unique needs based on their process requirements and accurately weighed to 0.001 ... Buffers , Salts , Sugars , Carbohydrates , ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... ... January 27, 2020 , ... ... secured financing from strategic investors led by Halma plc , a FTSE ... Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative from Halma ...
(Date:1/24/2020)... ... January 24, 2020 , ... Sierra Instruments, global leader ... and controllers ideal for BioPharm OEMS. Sierra also announces RedyCompact™ ... thermal instruments employ high-precision MEMS (Micro-Electro Mechanical Systems) technology utilizing an advanced, ultra-stable ...
(Date:1/22/2020)... ... January 21, 2020 , ... Microbial Discovery Group LLC (MDG) ... Industrial and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners ... over 30 years of sales experience working across multiple different market sectors such ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... vendor qualification process, a critical element of clinical trial set up and execution. ... vendor qualification process creates delays in initiation in 7% of clinical trials for ...
Breaking Biology Technology:
Cached News: